Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
29.33
+0.04 (0.14%)
At close: Jun 3, 2026, 4:00 PM EDT
29.49
+0.16 (0.54%)
After-hours: Jun 3, 2026, 6:23 PM EDT
Viking Therapeutics Stock Forecast
Stock Price Forecast
According to 20 analysts polled by S&P Global, Viking Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $92.58. The average 1-year stock price forecast is 215.65% higher than the current stock price, while the lowest is $34 (+15.92%) and the highest is $125 (+326.18%).
Price Target: $92.58 (+215.65%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Viking Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 12 | 12 | 12 | 12 | 13 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 1 | 1 | 1 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 18 | 18 | 18 | 19 | 19 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Buy Initiates $89 | Buy | Initiates | $89 | +203.44% | May 28, 2026 |
| Truist Financial | Truist Financial | Buy Initiates $75 → $83 | Buy | Initiates | $75 → $83 | +182.99% | May 27, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $107 | Buy | Reiterates | $107 | +264.81% | May 4, 2026 |
| Maxim Group | Maxim Group | Buy Reiterates $70 | Buy | Reiterates | $70 | +138.66% | May 1, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $95 | Buy | Maintains | $95 | +223.90% | Apr 30, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-4.81
from -3.19
EPS Next Year
-4.63
from -4.81
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | ||
| Avg | n/a | ||
| Low | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | |
| Avg | - | |
| Low | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -3.81 | ||
| Avg | -4.81 | ||
| Low | -5.72 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by S&P Global Market Intelligence. The data is sourced from Wall Street analysts. Data sources.